RÉSUMÉ
INTRODUCTION: Preterm labor is a common clinical problem in obstetrics. Since the majority of women with preterm labor eventually deliver at full term, biomarkers are needed to more accurately predict who will deliver preterm. Oxylipins, given their importance in inflammation regulation, are highly interesting in this respect since labor is an inflammatory process. METHODS: Eighty women with preterm labor before 34 weeks of gestation were enrolled in a prospective observational multi-center cohort study. Oxylipin levels of 67 analytes in plasma samples were analyzed by liquid chromatography coupled to tandem mass spectrometry. RESULTS: Twenty-one (26%) of the women delivered before 34 weeks of gestation, and of those women, fourteen delivered within 48 h of admission. Logistic multivariate regression showed that lower levels of 9,10-DiHODE were associated with delivery before 34 weeks of gestation (aOR 0.12 (0.024-0.62)) and within 48 h ((aOR 0.13 (0.019-0.93)). Furthermore, higher levels of 11,12-DiHETrE were associated with delivery before 34 weeks of gestation ((aOR 6.19 (1.17-32.7)) and higher levels of 8-HETE were associated with delivery within 48 h ((aOR 5.01 (1.13-22.14)). CONCLUSIONS: The oxylipin 9,10-DiHODE may be protective in preterm labor, both for delivery after 34 weeks of gestation and for delivery later than 48 h of admission, whereas 11,12-DiHETrE and 8-HETE display the opposite effect. Larger studies are needed to validate these mediators as biomarkers for prediction of preterm birth following preterm labor.
Sujet(s)
Oxylipines/sang , Naissance prématurée/sang , Adulte , Marqueurs biologiques/sang , Chromatographie en phase liquide/méthodes , Femelle , Âge gestationnel , Humains , Nouveau-né , Oxylipines/analyse , Admission du patient , Grossesse , Pronostic , Études prospectives , Spectrométrie de masse en tandem/méthodesRÉSUMÉ
BACKGROUND: Previous studies indicate a low incidence of appendicitis in third-trimester pregnancy, suggesting a protecting effect of pregnancy. This large population-based cohort study analyzes the association of appendicitis with pregnancy in more detail. The aim of the study was to investigate the incidence of appendicitis and negative appendectomy before, during and after pregnancy. METHODS: Cross-linking between two Swedish health registries provided data on appendectomy for all women in Sweden giving birth between 1973 and 2013. We analyzed the incidence rates (IR) of perforated and non-perforated appendicitis and negative appendectomy before, during and after pregnancy, and secular trends during the study period. Standardized incidence ratios (SIR) were estimated using age-, sex- and period-specific IR from the background population in Sweden. RESULTS: Some 3,888,452 pregnancies resulted in birth during the study period. An appendectomy was registered for 27,575 women in the interval starting one year before and ending two years after pregnancy. The incidence of appendicitis varied substantially during and after pregnancy. SIR for perforated appendicitis was 0.47 (95% CI 0.38-0.59) in the third trimester, 3.89 (2.92-5.18) peripartum, 2.20 (1.89-2.55) in the puerperium and 1.27 (1.19-1.36) in the year postpartum. The pattern was similar for non-perforated appendicitis. Negative appendectomy decreased postpartum. Incidence rate of non-perforated appendicitis and negative appendectomy decreased for both pregnant and non-pregnant women during the study period. CONCLUSIONS: The findings in this study suggest a protecting effect of pregnancy on the development of appendicitis, which is followed by a rebound effect after birth.
Sujet(s)
Appendicectomie/statistiques et données numériques , Appendicite/épidémiologie , Appendicite/chirurgie , Complications de la grossesse/épidémiologie , Complications de la grossesse/chirurgie , Études de cohortes , Femelle , Humains , Incidence , Mâle , Période de péripartum , Période du postpartum , Grossesse , Troisième trimestre de grossesse , Facteurs de protection , Enregistrements , Suède/épidémiologie , Jeune adulteRÉSUMÉ
Tuberculosis (TB) is a leading cause of morbidity and mortality in Thailand. Cytokines play important roles in defense against Mycobacterium tuberculosis infection. Interleukin (IL)-4 is one of the anti-inflammatory cytokines and has been found to be elevated in TB patients. The common polymorphisms in IL-4 gene, including IL-4-590C/T, IL-4-33C/T, and IL-4-variable number of tandem repeats (VNTR) intron 3 have been reported to be associated with risk for some diseases. The purpose of this study was to investigate possible associations between the above mentioned three common functional polymorphisms in the IL-4 gene in patients with pulmonary tuberculosis (PTB) in a Thai population. Forty three patients with PTB and 90 healthy control subjects were studied. The three common polymorphisms of the IL-4 gene were determined using polymerase chain reaction (PCR) and PCR-restriction fragment length polymorphism (PCR-RFLP). The allele and genotype frequencies of IL-4 -590 C/T, -33 C/T, VNTR intron 3 polymorphisms did not show significant differences between PTB patients and healthy controls (genotype: p=0.88, p=0.92, p=0.40; allele: p=0.38, p=0.44, p=0.53, respectively). However, the allele distribution of the IL-4 -590 C, -33 C, and VNTR R3 was higher among PTB patients (25.58%, 25.58%, 25.58%, respectively) than among control subjects (20%, 20.48%, 19.44%, respectively). This may suggest that IL-4-590C/T, -33C/T and VNTR intron 3 might play a role in susceptibility to PTB. A larger cohort may possibly help conclude our findings.
Sujet(s)
Interleukine-4/génétique , Répétitions minisatellites , Régions promotrices (génétique) , Tuberculose pulmonaire/génétique , Études cas-témoins , Prédisposition génétique à une maladie , Génotype , Humains , Introns , Réaction de polymérisation en chaîne , Polymorphisme de restriction , ThaïlandeRÉSUMÉ
@#Tuberculosis (TB) is a leading cause of morbidity and mortality in Thailand. Cytokines play important roles in defense against Mycobacterium tuberculosis infection. Interleukin (IL)-4 is one of the anti-inflammatory cytokines and has been found to be elevated in TB patients. The common polymorphisms in IL-4 gene, including IL-4-590C/T, IL-4-33C/T, and IL-4-variable number of tandem repeats (VNTR) intron 3 have been reported to be associated with risk for some diseases. The purpose of this study was to investigate possible associations between the above mentioned three common functional polymorphisms in the IL-4 gene in patients with pulmonary tuberculosis (PTB) in a Thai population. Forty three patients with PTB and 90 healthy control subjects were studied. The three common polymorphisms of the IL-4 gene were determined using polymerase chain reaction (PCR) and PCR-restriction fragment length polymorphism (PCR-RFLP). The allele and genotype frequencies of IL-4 -590 C/T, -33 C/T, VNTR intron 3 polymorphisms did not show significant differences between PTB patients and healthy controls (genotype: p=0.88, p=0.92, p=0.40; allele: p=0.38, p=0.44, p=0.53, respectively). However, the allele distribution of the IL-4 -590 C, -33 C, and VNTR R3 was higher among PTB patients (25.58%, 25.58%, 25.58%, respectively) than among control subjects (20%, 20.48%, 19.44%, respectively). This may suggest that IL-4-590C/T, -33C/T and VNTR intron 3 might play a role in susceptibility to PTB. A larger cohort may possibly help conclude our findings.
RÉSUMÉ
Although tremendous progress has been made in recent years in skin cancer care for organ transplant recipients, significant gaps remain in data-driven clinical guidelines, particularly for the treatment and prevention of cutaneous squamous cell carcinoma (cSCC), the most common malignancy among this population. In this review, we aim to summarize current knowledge around the management of cSCC and highlight the most significant gaps in knowledge that continue to pose challenges in the delivery of skin cancer care for organ transplant recipients. We suggest future directions for research that will bridge existing gaps and establish evidence-driven guidelines for primary prevention, screening and treatment of cSCC in this high-risk patient population.
Sujet(s)
Carcinome épidermoïde/thérapie , Transplantation d'organe/effets indésirables , Tumeurs cutanées/thérapie , Receveurs de transplantation , Antimétabolites antinéoplasiques/usage thérapeutique , Capécitabine/usage thérapeutique , Carcinome épidermoïde/prévention et contrôle , Comportement en matière de santé , Humains , Immunosuppression thérapeutique/effets indésirables , Immunosuppression thérapeutique/méthodes , Immunosuppresseurs/effets indésirables , Kératoacanthome/prévention et contrôle , Kératoacanthome/thérapie , Métastase tumorale , Nicotinamide/usage thérapeutique , Infections à papillomavirus/prévention et contrôle , Vaccins contre les papillomavirus , Photodermatoses/prévention et contrôle , Photodermatoses/thérapie , Qualité de vie , Radiothérapie adjuvante , Rétinoïdes/usage thérapeutique , Tumeurs cutanées/prévention et contrôle , Lumière du soleil/effets indésirables , Complexe vitaminique B/usage thérapeutiqueRÉSUMÉ
Pregnancy-associated malaria (PAM) is a severe form of the disease caused by sequestration of Plasmodium falciparum-infected red blood cells (iRBCs) in the developing placenta. Pathogenesis of PAM is partially based on immunopathology, with frequent monocyte infiltration into the placenta. Neutrophils are abundant blood cells that are essential for immune defence but may also cause inflammatory pathology. Their role in PAM remains unclear. We analysed neutrophil alterations in the context of PAM to better understand their contribution to disease development. Pregnant women exposed to Plasmodium falciparum had decreased numbers of circulating neutrophils. Placental-like BeWo cells stimulated with malaria parasites produced the neutrophil chemoattractant IL-8 and recruited neutrophils in a trans-well assay. Finally, immunostaining of a PAM placenta confirmed neutrophil accumulation in the intervillous space. Our data indicate neutrophils may play a role in placental malaria and should be more closely examined as an etiological agent in the pathophysiology of disease.
Sujet(s)
Paludisme à Plasmodium falciparum/immunologie , Granulocytes neutrophiles/métabolisme , Plasmodium falciparum/immunologie , Complications parasitaires de la grossesse/immunologie , Chimiotaxie , Études de cohortes , Femelle , Humains , Granulocytes neutrophiles/immunologie , Placenta/immunologie , Grossesse , Tanzanie , Jeune adulteRÉSUMÉ
Malaria is a life-threatening disease caused by parasites of the Plasmodium genus. In many parts of the world, the parasites have developed resistance to a number of antimalarial agents. Key interventions to control malaria include prompt and effective treatment with artemisinin-based combination therapies, use of insecticidal nets by individuals at risk and active research into malaria vaccines. Protection against malaria through vaccination was demonstrated more than 30 years ago when individuals were vaccinated via repeated bites by Plasmodium falciparum-infected and irradiated but still metabolically active mosquitoes. However, vaccination with high doses of irradiated sporozoites injected into humans has long been considered impractical. Yet, following recent success using whole-organism vaccines, the approach has received renewed interest; it was recently reported that repeated injections of irradiated sporozoites increased protection in 80 vaccinated individuals. Other approaches include subunit malaria vaccines, such as the current leading candidate RTS,S (consisting of fusion between a portion of the P. falciparum-derived circumsporozoite protein and the hepatitis B surface antigen), which has been demonstrated to induce reasonably good protection. Although results have been encouraging, the level of protection is generally considered to be too low to achieve eradication of malaria. There is great interest in developing new and better formulations and stable delivery systems to improve immunogenicity. In this review, we will discuss recent strategies to develop efficient malaria vaccines.
Sujet(s)
Vaccins contre le paludisme/immunologie , Paludisme/prévention et contrôle , Adjuvants immunologiques/administration et posologie , Antigènes de protozoaire/immunologie , Vaccin BCG/administration et posologie , Essais cliniques comme sujet , Systèmes de délivrance de médicaments , Érythrocytes/immunologie , Érythrocytes/parasitologie , Humains , Étapes du cycle de vie/immunologie , Paludisme/immunologie , Vaccins contre le paludisme/administration et posologie , Vaccins contre le paludisme/pharmacologie , Plasmodium falciparum/croissance et développement , Plasmodium falciparum/immunologie , Sporozoïtes/immunologie , Technologie pharmaceutiqueRÉSUMÉ
It has been previously shown that there are some interethnic differences in susceptibility to malaria between two sympatric ethnic groups of Mali, the Fulani and the Dogon. The lower susceptibility to Plasmodium falciparum malaria seen in the Fulani has not been fully explained by genetic polymorphisms previously known to be associated with malaria resistance, including haemoglobin S (HbS), haemoglobin C (HbC), alpha-thalassaemia and glucose-6-phosphate dehydrogenase (G6PD) deficiency. Given the observed differences in the distribution of FcγRIIa allotypes among different ethnic groups and with malaria susceptibility that have been reported, we analysed the rs1801274-R131H polymorphism in the FcγRIIa gene in a study of Dogon and Fulani in Mali (n = 939). We confirm that the Fulani have less parasite densities, less parasite prevalence, more spleen enlargement and higher levels of total IgG antibodies (anti-CSP, anti-AMA1, anti-MSP1 and anti-MSP2) and more total IgE (P < 0.05) compared with the Dogon ethnic group. Furthermore, the Fulani exhibit higher frequencies of the blood group O (56.5%) compared with the Dogon (43.5%) (P < 0.001). With regard to the FcγRIIa polymorphism and allele frequency, the Fulani group have a higher frequency of the H allele (Fulani 0.474, Dogon 0.341, P < 0.0001), which was associated with greater total IgE production (P = 0.004). Our findings show that the FcγRIIa polymorphism might have an implication in the relative protection seen in the Fulani tribe, with confirmatory studies required in other malaria endemic settings.
Sujet(s)
Prédisposition génétique à une maladie/génétique , Paludisme à Plasmodium falciparum/génétique , Polymorphisme de nucléotide simple , Récepteurs du fragment Fc des IgG/génétique , Adolescent , Anticorps antiprotozoaires/immunologie , Enfant , Enfant d'âge préscolaire , Ethnies/génétique , Femelle , Fréquence d'allèle , Prédisposition génétique à une maladie/ethnologie , Génotype , Interactions hôte-parasite , Humains , Immunoglobuline E/immunologie , Immunoglobuline G/immunologie , Nourrisson , Nouveau-né , Paludisme à Plasmodium falciparum/ethnologie , Paludisme à Plasmodium falciparum/immunologie , Mâle , Mali/épidémiologie , Plasmodium falciparum/immunologie , Plasmodium falciparum/physiologie , Prévalence , Splénomégalie/génétique , Splénomégalie/immunologie , Splénomégalie/parasitologieRÉSUMÉ
An antileishmanial activity of quinolinic alkaloids from Galipea longiflora Krause, known as Evanta, has been demonstrated. We have previously shown that, apart from its leishmanicidal effect, in vitro pretreatment of spleen cells with an alkaloid extract of Evanta (AEE) interfered with the proliferation and interferon-γ production in lymphocytes polyclonally activated either with concanavalin A or anti-CD3. In the present study, we investigated if AEE could interfere with antigen-specific lymphocyte activation. We found that in vitro and in vivo treatment reduced recall lymphocyte responses, as measured by IFN-γ production (55% and 63% reduction compared to untreated cells, respectively). Apart from IFN-γ, the production of IL-12 and TNF was also suppressed. No effects were observed for meglumine antimoniate (SbV), the conventional drug used to treat leishmaniasis. When mice infected with Leishmania braziliensis promastigotes in the hind footpad were treated with AEE, the dynamics of the infection changed and the footpath thickness was efficiently controlled. The parasite load was also reduced but to a lesser extent than upon treatment with SbV. Combined treatment efficiently controlled both the thickness and parasite load as smaller lesions during the entire course of the infection were seen in the mice treated with AEE plus SbV compared with AEE or SbV alone. We discuss the benefits of combined administration of AEE plus SbV.
Sujet(s)
Alcaloïdes/administration et posologie , Antiprotozoaires/administration et posologie , Leishmania brasiliensis/immunologie , Leishmaniose/traitement médicamenteux , Extraits de plantes/administration et posologie , Quinoléines/administration et posologie , Rutaceae/composition chimique , Lymphocytes T/effets des médicaments et des substances chimiques , Animaux , Antigènes de protozoaire/immunologie , Cellules cultivées , Cytokines/métabolisme , Femelle , Immunosuppression thérapeutique , Médiateurs de l'inflammation/métabolisme , Leishmaniose/immunologie , Activation des lymphocytes/effets des médicaments et des substances chimiques , Méglumine/administration et posologie , Antimoniate de méglumine , Souris , Souris de lignée C57BL , Composés organométalliques/administration et posologie , Charge parasitaire , Lymphocytes T/immunologieRÉSUMÉ
Fulani of Mali are known for their lower susceptibility to Plasmodium falciparum malaria than their neighbours, the Dogon, despite similar transmission conditions. However, the mechanisms underlying these differences are poorly understood, particularly those concerning antigenspecific immune responses. The Apical Membrane Antigen 1 (AMA1) and the Merozoite Surface Antigen 1 (MSP1) are two malaria vaccine candidates, which play a pivotal role during the invasion of parasites into erythrocytes, and in the case of AMA1, of hepatocytes. Therefore, we analyzed the level of anti-AMA1 and anti-MSP1 antibodies (FVO and 3D7 alleles), by using ELISA (Enzyme Linked Immuno Sorbent Assay) to investigate whether there are differences between the two ethnic groups. Our results show that the splenic rate, the level of anti-AMA1 and anti-MSP1 were significantly higher in Fulani compared to Dogon; while the parasite rate was lower in Fulani group compared to Dogon. Our results suggest that the lower susceptibility of Fulani to malaria could be due to the higher specific humoral responses against AMA1 and MSP 1 in Fulani's ethnic group compared to Dogon.
Sujet(s)
Antigènes de protozoaire/immunologie , Immunité humorale , Paludisme à Plasmodium falciparum/ethnologie , Paludisme à Plasmodium falciparum/immunologie , Protéine-1 de surface du mérozoïte/immunologie , Plasmodium falciparum/immunologie , Adolescent , Adulte , Enfant , Enfant d'âge préscolaire , Ethnies , Humains , Immunité humorale/physiologie , Paludisme à Plasmodium falciparum/sang , Paludisme à Plasmodium falciparum/épidémiologie , Mali/épidémiologie , Mali/ethnologie , Adulte d'âge moyen , Études séroépidémiologiques , Sympatrie/immunologie , Sympatrie/physiologie , Jeune adulteRÉSUMÉ
A malaria vaccine targeting Plasmodium falciparum remains a strategic goal for malaria control. If a polyvalent vaccine is to be developed, its subunits would probably be chosen based on immunogenicity (concentration of elicited antibodies) and associations of selected antigens with protection. We propose an additional possible selection criterion for the inclusion of subunit antigens; that is, coordination between elicited antibodies. For the quantitative estimation of this coordination, we developed a malaria serological map (MSM). Construction of the MSM was based on three categories of variables: (i) malaria antigens, (ii) total IgG and IgG subclasses, (iii) different sources of plasma. To validate the MSM, in this study, we used four malaria antigens (AMA1, MSP2-3D7, MSP2-FC27 and Pf332-C231) and re-grouped the plasma samples into five pairs of subsets based on age, gender, residence, HbAS and malaria morbidity in 9 years. The plasma total IgG and IgG subclasses to the test antigens were measured, and the whole material was used for the MSM construction. Most of the variables in the MSM were previously tested and their associations with malaria morbidity are known. The coordination of response to each antigens pair in the MSM was quantified as the correlation rate (CR = overall number of significant correlations/total number of correlations × 100 %). Unexpectedly, the results showed that low CRs were mostly associated with variables linked with malaria protection and the antigen eliciting the least CRs was the one associated with protection. The MSM is, thus, of potential value for vaccine design and understanding of malaria natural immunity.
Sujet(s)
Anticorps antiprotozoaires/sang , Variation des antigènes , Antigènes de protozoaire/immunologie , Techniques immunologiques/méthodes , Paludisme à Plasmodium falciparum/immunologie , Plasmodium falciparum/immunologie , Adolescent , Adulte , Sujet âgé , Enfant , Femelle , Humains , Immunoglobuline G/sang , Vaccins contre le paludisme/immunologie , Mâle , Adulte d'âge moyen , Jeune adulteRÉSUMÉ
In regions of high Plasmodium falciparum malaria endemicity, certain erythrocyte polymorphisms confer resistance to severe disease. In this study, we evaluate the role of the sickle cell trait (HbS) and ABO blood groups in the clinical manifestations of childhood malaria in Southwest Nigeria. The subjects comprised 3100 children (53% males, median age 39 months), including 1400 children with uncomplicated malaria, 1000 children with asymptomatic malaria and 700 with severe malaria. Haemoglobin (Hb) types were determined using electrophoresis and serum agglutination techniques were used to determine ABO blood groups. Blood group O was the commonest ABO blood group (47.7%) in the study population, the others were A (22.5%), B (25.2%) and AB (4.6%). The frequencies of the HbAS and HbAC were 14.4% and 5.8%, respectively. In regression models adjusting for age, gender, parasite density and blood group, HbAS was associated with a reduced risk of severe malaria OR=0.46 (CI(95%): 0.273-0.773). Among severe malaria subjects, HbAS was associated with significantly lower parasite densities. The protective effect of blood group O was demonstrated with a decreased risk of severe malaria OR=0.743 (CI(95%): 0.566-0.976) after adjusting for age, gender and parasite density and Hb genotype. Blood group B was associated with increased risk of severe malaria OR=1.638 (CI(95%): 1.128-2.380) after adjusting for age, gender, packed cell volume, parasite density and Hb genotype. We have confirmed from this large study of Nigerian children the major protective effective of the sickle cell heterozygous state against both cerebral malaria and severe malarial anaemia. We also show that the B blood group is associated with an increased risk of severe malaria. In conclusion, the sickle cell haemoglobin type and ABO groups modulate the risk of severe malaria in Nigerian children.
Sujet(s)
Système ABO de groupes sanguins/génétique , Prédisposition génétique à une maladie , Paludisme à Plasmodium falciparum/physiopathologie , Paludisme à Plasmodium falciparum/parasitologie , Indice de gravité de la maladie , Trait drépanocytaire/génétique , Anémie/épidémiologie , Anémie/génétique , Anémie/parasitologie , Anémie/physiopathologie , Enfant , Enfant d'âge préscolaire , Femelle , Fréquence d'allèle , Humains , Nourrisson , Paludisme cérébral/épidémiologie , Paludisme cérébral/génétique , Paludisme cérébral/parasitologie , Paludisme cérébral/physiopathologie , Paludisme à Plasmodium falciparum/épidémiologie , Paludisme à Plasmodium falciparum/génétique , Mâle , Nigeria/épidémiologie , Plasmodium falciparum/pathogénicitéRÉSUMÉ
Thyroid cancer incidence has increased worldwide during the previous decades. In this nationwide study, we aimed to identify the overall incidence of thyroid cancer in Denmark during 66 years (1943-2008) and incidences of the four main histological types of thyroid cancer from 1978 to 2008. Data were obtained from the nationwide Danish Cancer Registry, and we focused especially on the period after implementation of compulsory iodine supplementation, which was established on a national level in 2000. We calculated age-standardized incidence rates per 100,000 person-years, and age-period-cohort models were fitted to describe trends in incidence. To quantify trends in incidence over time, log-linear Poisson models were used to estimate annual percentage change. From 1943 to 2008, 1,947 men (29%) and 4,682 women (71%) were diagnosed with thyroid cancer. The age-standardized incidence increased in both sexes; in men from 0.41 to 1.57 per 100,000 and from 0.90 to 4.11 per 100,000 in women, corresponding to a significant average annual percentage change of 1.7 and 1.8%, respectively. The incidence increased with younger birth cohorts. The rise was almost exclusively caused by papillary carcinomas, and it was particularly present during the last decades of the study period. It cannot be ruled out that iodine supplementation may play a role for the risk of thyroid cancer, but as the strongest increase in incidence began in the years before the implementation, it is likely that improvement in diagnostic modalities increased diagnostic activity, and/or new unknown risk factors are also important contributors to the increase.
Sujet(s)
Compléments alimentaires , Iode , Tumeurs de la thyroïde/épidémiologie , Facteurs âges , Sujet âgé , Danemark/épidémiologie , Femelle , Humains , Incidence , Mâle , Adulte d'âge moyen , Enregistrements , Tumeurs de la thyroïde/mortalité , Tumeurs de la thyroïde/anatomopathologieRÉSUMÉ
FcγRIIa is known to be polymorphic; and certain variants are associated with different susceptibilities to malaria. Studies involving the Fulani ethnic group reported an ethnic difference in FcγRIIa-R131H genotype frequencies between the Fulani and other sympatric groups. No previous studies have addressed these questions in Burkina Faso. This study aimed to assess the influence of FcγRIIa-R131H polymorphism on anti-falciparum malaria IgG and IgG subclass responses in the Fulani and the Mossi ethnic groups living in Burkina Faso. Healthy adults more than 20 years old belonging to the Mossi or the Fulani ethnic groups were enrolled for the assessment of selected parasitological, immunological and genetic variables in relation to their susceptibility to malaria. The prevalence of the Plasmodium falciparum infection frequency was relatively low in the Fulani ethnic group compared to the Mossi ethnic group. For all tested antigens, the Fulani had higher antibody levels than the Mossi group. In both ethnic groups, a similar distribution of FcγRIIa R131H polymorphism was found. Individuals with the R allele of FcγRIIa had higher antibody levels than those with the H allele. This study confirmed that malaria infection affected less the Fulani group than the Mossi group. FcγRIIa-R131H allele distribution is similar in both ethnic groups, and higher antibody levels are associated with the FcγRIIa R allele compared to the H allele.
Sujet(s)
Prédisposition génétique à une maladie/génétique , Immunoglobuline G/immunologie , Paludisme à Plasmodium falciparum/ethnologie , Paludisme à Plasmodium falciparum/génétique , Polymorphisme de nucléotide simple , Récepteurs du fragment Fc des IgG/génétique , Adulte , Burkina , Test ELISA , Femelle , Génotype , Humains , Immunoglobuline G/génétique , Paludisme à Plasmodium falciparum/immunologie , Mâle , Réaction de polymérisation en chaîne , Polymorphisme de nucléotide simple/génétiqueRÉSUMÉ
The anti-malarial IgG immune response during the lengthy and dry season in areas of low malaria transmission as in Eastern Sudan is largely unknown. In this study, ELISA was used for the measurement of pre-existing total IgG and IgG subclasses to a panel of malaria antigens, MSP2-3D7, MSP2-FC27, AMA-1 and Pf332-C231. The results showed that the antibody responses were predominantly age dependent, antigen specific, and their lifespan was at least 5-6 month long. Generally, the IgG3 was most abundant IgG subclass, and the most recognized antigen was Pf332-C231. Furthermore, the correlation between the levels of IgG subclasses was strongest between IgG1 and IgG3, which were more predictive to the total IgG levels. Finally, the response pattern of each of the IgG subclasses to the different test antigens that were spanning the dry season and the correlation between these responses were described in details for the first time.
Sujet(s)
Anticorps antiprotozoaires/sang , Antigènes de protozoaire/immunologie , Immunoglobuline G/sang , Paludisme/immunologie , Protéines membranaires/immunologie , Protéines de protozoaire/immunologie , Adolescent , Adulte , Sujet âgé , Anticorps antiprotozoaires/immunologie , Enfant , Test ELISA , Femelle , Humains , Immunoglobuline G/immunologie , Mâle , Adulte d'âge moyen , Plasmodium falciparum/immunologie , Réaction de polymérisation en chaîne , Saisons , SoudanRÉSUMÉ
Previous studies have implicated reactive antibodies to the low molecular weight rhoptry-associated proteins (RAP-1, RAP-2/RSP-2 and RAP-3) in erythroid cell destruction during Plasmodium falciparum infection. In this pilot study, the frequency, specificity and functional capacity of naturally acquired anti-RAP-2/RSP-2 antibodies were investigated in the sera of anaemic and nonanaemic malaria-infected Cameroonian children. All sera recognized RAP-2/RSP-2 by FACS, irrespective of the clinical status of the subjects. However, the anaemic children showed higher levels of IgG antibodies than the nonanaemic group, while both groups showed similar levels of IgM antibodies. Only few individuals had detectable levels of RAP-2/RSP-2-specific IgG1 and IgG3 subclass antibodies, while no IgG2 and IgG4 subclass antibodies were detected in these subjects. By ELISA, the anaemic group tended to show higher levels of antibodies to RAP-2/RSP-2 regarding all antibody classes tested, except for IgG4 and IgE. Unexpectedly, sera from the nonanaemic group activated complement to a greater extent than those from the anaemic group. These results need to be confirmed in extended studies but indicate that the effector functions of the RAP-2/RSP-2-reactive antibodies may be more important than their amounts. Such antibodies could play a role in both immunity and pathogenesis during P. falciparum infection.
Sujet(s)
Anémie/immunologie , Anémie/parasitologie , Anticorps antiprotozoaires/sang , Paludisme à Plasmodium falciparum/complications , Paludisme à Plasmodium falciparum/immunologie , Plasmodium falciparum/immunologie , Protéines de protozoaire/immunologie , Cameroun , Enfant , Enfant d'âge préscolaire , Test ELISA , Femelle , Humains , Immunoglobuline G/sang , Nourrisson , MâleRÉSUMÉ
Antimicrobial drug use and overuse have been a topic of interest for many years, lately focusing on the growing resistance worldwide. This study was conducted in a small Indian hospital, where more than 80% of all admitted patients received antimicrobial drugs. Penicillin, gentamycin, co-trimoxazole, ciprofloxacin and metronidazole were most commonly used and all antimicrobial drugs were given empirically with no confirmation of the infective agent. Reports of increasing resistance to antimicrobial drugs in India, and elsewhere, necessitates a focus on how antimicrobials drugs are used in relation to investigations of resistance patterns among the local strains of pathogens. This study may be considered a base-line study, though of relevance for other hospitals, in particular in low-income areas, where development of resistance to standard antimicrobial drugs may have severe implications for both patients and health managers.
Sujet(s)
Anti-infectieux/usage thérapeutique , Ordonnances médicamenteuses/statistiques et données numériques , Utilisation médicament/statistiques et données numériques , Patients hospitalisés/statistiques et données numériques , Adolescent , Adulte , Femelle , Capacité hospitalière inférieure à 100 lits , Hôpitaux religieux , Humains , Inde , Durée du séjour , Mâle , Adulte d'âge moyen , Types de pratiques des médecins/statistiques et données numériques , Études prospectives , Population rurale , Jeune adulteRÉSUMÉ
Fibroblast growth factor receptor 3 (FGFR3) gene mutations in the germline are well-known causes of skeletal syndromes. Somatic FGFR3 mutations have been found in malignant neoplasms and more recently in several cutaneous elements. We present a 14-year-old girl with mild hypochondroplasia who developed acanthosis nigricans. The report of a K650Q mutation in the FGFR3 gene in a similar case prompted us to conduct a point mutation analysis. The K650Q mutation was confirmed, but in contrast to the previous case, we additionally report findings of hyperinsulinemia. In the recent literature, an increasing number of different cutaneous elements have been found to harbor mutations of FGFR3, suggesting that FGFR3 plays a role in the pathogenesis of these elements. We review the present literature, describing studies in which FGFR3 mutations have been investigated in skin lesions: primarily seborrheic keratoses and epidermal nevi, but also other benign skin tumors and a single case of a squamous cell carcinoma. In addition, an overview of the FGFR3 point mutations in relation to each cutaneous element is given. Based on the current knowledge, it seems likely that these cutaneous lesions have a common genetic background. Our case shows that FGFR3 mutation analysis should be considered in case of the coexistence of acanthosis nigricans and a skeletal dysplasia. Testing for hyperinsulinemia is essential, also if a gene mutation is confirmed.
Sujet(s)
Acanthosis nigricans/génétique , Nanisme/génétique , Hyperinsulinisme/génétique , Mutation ponctuelle , Récepteur de type 3 des facteurs de croissance fibroblastique/génétique , Acanthosis nigricans/diagnostic , Acanthosis nigricans/anatomopathologie , Adolescent , Glycémie/effets des médicaments et des substances chimiques , Peptide C/sang , Nanisme/traitement médicamenteux , Nanisme/anatomopathologie , Femelle , Hormone de libération des gonadotrophines/usage thérapeutique , Hormone de croissance humaine/usage thérapeutique , Humains , Hyperinsulinisme/diagnostic , Hyperinsulinisme/traitement médicamenteux , Kératose séborrhéique/génétique , Metformine/usage thérapeutiqueRÉSUMÉ
Plasmodium falciparum infection causes transient immunosuppression during the parasitaemic stage. However, the immune response during simultaneous infections with both P. vivax and P. falciparum has been investigated rarely. In particular, it is not clear whether the host's immune response to malaria will be different when infected with a single or mixed malaria species. Phenotypes of T cells from mixed P. vivax-P. falciparum (PV-PF) infection were characterized by flow cytometry, and anti-malarial antibodies in the plasma were determined by an enzyme-linked immunosorbent assay. We found the percentage of CD3+delta2+-T cell receptor (TCR) T cells in the acute-mixed PV-PF infection and single P. vivax infection three times higher than in the single P. falciparum infection. This implied that P. vivax might lead to the host immune response to the production of effector T killer cells. During the parasitaemic stage, the mixed PV-PF infection had the highest number of plasma antibodies against both P. vivax and P. falciparum. Interestingly, plasma from the group of single P. vivax or P. falciparum malaria infections had both anti-P. vivax and anti-P. falciparum antibodies. In addition, antigenic cross-reactivity of P. vivax or P. falciparum resulting in antibodies against both malaria species was shown in the supernatant of lymphocyte cultures cross-stimulated with either antigen of P. vivax or P. falciparum. The role of delta2 +/- TCR T cells and the antibodies against both species during acute mixed malaria infection could have an impact on the immunity to malaria infection.
Sujet(s)
Anticorps antiprotozoaires/sang , Paludisme à Plasmodium falciparum/immunologie , Paludisme à Plasmodium vivax/immunologie , Parasitémie/immunologie , Plasmodium vivax/immunologie , Adulte , Animaux , Anticorps antiprotozoaires/immunologie , Spécificité des anticorps , Antigènes de protozoaire/immunologie , Cellules cultivées/effets des médicaments et des substances chimiques , Cellules cultivées/immunologie , Réactions croisées , Femelle , Fièvre/étiologie , Humains , Activation des lymphocytes/effets des médicaments et des substances chimiques , Paludisme à Plasmodium falciparum/sang , Paludisme à Plasmodium falciparum/complications , Paludisme à Plasmodium vivax/sang , Paludisme à Plasmodium vivax/complications , Mâle , Adulte d'âge moyen , Parasitémie/sang , Récepteur lymphocytaire T antigène, gamma-delta/immunologie , Sous-populations de lymphocytes T/effets des médicaments et des substances chimiques , Sous-populations de lymphocytes T/immunologie , Jeune adulteRÉSUMÉ
Traditional medicine and scientific studies have shown that the raw extract of Evanta [Galipea longiflora, Angostura longiflora (Krause) Kallunki] exhibits anti-leishmanial activity. We hypothesized that the healing observed when using this plant might not only be due to the direct action on the parasite, but possibly to a parallel effect on the host immune response to the parasite involved in the healing process. We show here that an alkaloid extract of Evanta (AEE) directly killed the parasite already at a dose of 10 microg/ml, but at this low concentration, AEE did not have a major effect on viability and proliferation of eukaryotic cells. The whole extract was also found to be stronger than 2-phenylquinoline, the most prominent alkaloid in AEE. AEE was not directly stimulating B or T cells or J774 macrophages. However, it interfered with the activation of both mouse and human T cells, as revealed by a reduction of in vitro cellular proliferation and interferon-gamma (IFN-gamma) production. The effect was more evident when the cells were pretreated with AEE and subsequently stimulated with the polyclonal T-cell activators Concanavalin A and anti-CD3. Taken together, our results suggest that Evanta have a direct leishmanicidal effect and due to the effect on IFN-gamma production it might contribute to control the chronic inflammatory reaction that characterize Leishmania infection pathology, but in vivo studies are necessary to corroborate this finding.